The results showed that circFOXK2 and CCND1 are expressed significantly higher in a number of cancer types we tested including colorectal cancer (CRC), esophageal squamous cell carcinoma (ESCC), and prostate cancer (PRAD) (Fig. 7 G and H). Here, CCND1 is linked to prostate adenocarcinoma.